
Anna Pagonakis
Examiner (ID: 6985)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1614, 4173, 1609, 1628, OPET |
| Total Applications | 1238 |
| Issued Applications | 444 |
| Pending Applications | 73 |
| Abandoned Applications | 723 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9530256
[patent_doc_number] => 08754128
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-17
[patent_title] => 'Dioxoanthracene sulphonate derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/743212
[patent_app_country] => US
[patent_app_date] => 2008-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 3787
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12743212
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/743212 | Dioxoanthracene sulphonate derivatives | Nov 13, 2008 | Issued |
Array
(
[id] => 8435599
[patent_doc_number] => 08283367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-09
[patent_title] => 'Proteasome inhibitors and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 12/265998
[patent_app_country] => US
[patent_app_date] => 2008-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42884
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12265998
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/265998 | Proteasome inhibitors and methods of using the same | Nov 5, 2008 | Issued |
Array
(
[id] => 6292237
[patent_doc_number] => 20100239523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'TLR MODULATORS AND METHODS FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/740690
[patent_app_country] => US
[patent_app_date] => 2008-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9371
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20100239523.pdf
[firstpage_image] =>[orig_patent_app_number] => 12740690
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/740690 | TLR MODULATORS AND METHODS FOR USING THE SAME | Oct 29, 2008 | Abandoned |
Array
(
[id] => 6275912
[patent_doc_number] => 20100256148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'USE OF CFMS INHIBITOR FOR TREATING OR PREVENTING BONE CANCER AND THE BONE LOSS AND BONE PAIN ASSOCIATED WITH BONE CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/741118
[patent_app_country] => US
[patent_app_date] => 2008-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 55126
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256148.pdf
[firstpage_image] =>[orig_patent_app_number] => 12741118
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/741118 | USE OF CFMS INHIBITOR FOR TREATING OR PREVENTING BONE CANCER AND THE BONE LOSS AND BONE PAIN ASSOCIATED WITH BONE CANCER | Oct 28, 2008 | Abandoned |
Array
(
[id] => 6517023
[patent_doc_number] => 20100261689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'PYRROLO [1,2-C] IMIDAZOLE DERIVATIVES FOR USE IN THE PROPHYLAXIS OR TREATMENT OF CANCER WHICH IS REFRACTORY TO KNOWN CANCER THERAPIES'
[patent_app_type] => utility
[patent_app_number] => 12/740677
[patent_app_country] => US
[patent_app_date] => 2008-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12462
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261689.pdf
[firstpage_image] =>[orig_patent_app_number] => 12740677
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/740677 | PYRROLO [1,2-C] IMIDAZOLE DERIVATIVES FOR USE IN THE PROPHYLAXIS OR TREATMENT OF CANCER WHICH IS REFRACTORY TO KNOWN CANCER THERAPIES | Oct 27, 2008 | Abandoned |
Array
(
[id] => 5331302
[patent_doc_number] => 20090111779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'METHODS OF USE FOR 2,5-DIHYDROXYBENZENE SULFONIC ACID COMPOUNDS FOR THE TREATMENT OF CANCER, ROSACEA AND PSORIASIS'
[patent_app_type] => utility
[patent_app_number] => 12/257854
[patent_app_country] => US
[patent_app_date] => 2008-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 11980
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12257854
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/257854 | Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis | Oct 23, 2008 | Issued |
Array
(
[id] => 6617505
[patent_doc_number] => 20100099775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'METHOD FOR AMELIORATING OF POST-ANESTHETIC RECOVERY'
[patent_app_type] => utility
[patent_app_number] => 12/253667
[patent_app_country] => US
[patent_app_date] => 2008-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2165
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099775.pdf
[firstpage_image] =>[orig_patent_app_number] => 12253667
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/253667 | METHOD FOR AMELIORATING OF POST-ANESTHETIC RECOVERY | Oct 16, 2008 | Abandoned |
Array
(
[id] => 6508738
[patent_doc_number] => 20100210650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/680657
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4947
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20100210650.pdf
[firstpage_image] =>[orig_patent_app_number] => 12680657
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/680657 | ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER | Oct 9, 2008 | Abandoned |
Array
(
[id] => 6267687
[patent_doc_number] => 20100298398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'THROMBOPOIETIN RECEPTOR AGONIST (TPORA) KILLS ACUTE HUMAN MYELOID LEUKEMIA CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/682114
[patent_app_country] => US
[patent_app_date] => 2008-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 8967
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298398.pdf
[firstpage_image] =>[orig_patent_app_number] => 12682114
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682114 | Thrombopoietin receptor agonist (TpoRA) kills acute human myeloid leukemia cells | Oct 7, 2008 | Issued |
Array
(
[id] => 5441909
[patent_doc_number] => 20090093548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'COLCHINE COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/246034
[patent_app_country] => US
[patent_app_date] => 2008-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 24208
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20090093548.pdf
[firstpage_image] =>[orig_patent_app_number] => 12246034
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/246034 | COLCHINE COMPOSITIONS AND METHODS | Oct 5, 2008 | Abandoned |
Array
(
[id] => 6603272
[patent_doc_number] => 20100323033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'CANCER SENSITIZER COMPRISING CHLOROGENIC ACID'
[patent_app_type] => utility
[patent_app_number] => 12/740978
[patent_app_country] => US
[patent_app_date] => 2008-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2507
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0323/20100323033.pdf
[firstpage_image] =>[orig_patent_app_number] => 12740978
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/740978 | CANCER SENSITIZER COMPRISING CHLOROGENIC ACID | Sep 30, 2008 | Abandoned |
Array
(
[id] => 6631183
[patent_doc_number] => 20100311765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'METABOLIC DEGRADATION INHIBITORS FOR ANTI-HYPERPROLIFERATIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/679795
[patent_app_country] => US
[patent_app_date] => 2008-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4648
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311765.pdf
[firstpage_image] =>[orig_patent_app_number] => 12679795
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/679795 | METABOLIC DEGRADATION INHIBITORS FOR ANTI-HYPERPROLIFERATIVE AGENTS | Sep 25, 2008 | Abandoned |
Array
(
[id] => 5441872
[patent_doc_number] => 20090093511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'Mast cell stabilizers in the treatment of obesity'
[patent_app_type] => utility
[patent_app_number] => 12/232789
[patent_app_country] => US
[patent_app_date] => 2008-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6476
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20090093511.pdf
[firstpage_image] =>[orig_patent_app_number] => 12232789
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/232789 | Mast cell stabilizers in the treatment of obesity | Sep 23, 2008 | Issued |
Array
(
[id] => 7733419
[patent_doc_number] => 20120015919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'THERAPIES FOR TREATING CANCER USING COMBINATIONS OF COX-2 INHIBITORS AND AROMATASE INHIBITORS OR COMBINATIONS OF COX-2 INHIBITORS AND ESTROGEN RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/132893
[patent_app_country] => US
[patent_app_date] => 2008-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21842
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015919.pdf
[firstpage_image] =>[orig_patent_app_number] => 13132893
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/132893 | THERAPIES FOR TREATING CANCER USING COMBINATIONS OF COX-2 INHIBITORS AND AROMATASE INHIBITORS OR COMBINATIONS OF COX-2 INHIBITORS AND ESTROGEN RECEPTOR ANTAGONISTS | Sep 22, 2008 | Abandoned |
Array
(
[id] => 6262568
[patent_doc_number] => 20100297113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/679828
[patent_app_country] => US
[patent_app_date] => 2008-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 43906
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297113.pdf
[firstpage_image] =>[orig_patent_app_number] => 12679828
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/679828 | Quinone derivatives, pharmaceutical compositions, and uses thereof | Sep 21, 2008 | Issued |
Array
(
[id] => 5404536
[patent_doc_number] => 20090239850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'Kinase protein binding inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/283826
[patent_app_country] => US
[patent_app_date] => 2008-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 38294
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239850.pdf
[firstpage_image] =>[orig_patent_app_number] => 12283826
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/283826 | Kinase modulating compounds and uses thereof for treatment of cancer | Sep 14, 2008 | Issued |
Array
(
[id] => 5272216
[patent_doc_number] => 20090075992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Pteridine Derivatives as Nitric Oxide Synthase Activators'
[patent_app_type] => utility
[patent_app_number] => 12/207631
[patent_app_country] => US
[patent_app_date] => 2008-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7147
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075992.pdf
[firstpage_image] =>[orig_patent_app_number] => 12207631
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/207631 | Pteridine Derivatives as Nitric Oxide Synthase Activators | Sep 9, 2008 | Abandoned |
Array
(
[id] => 6002941
[patent_doc_number] => 20110118222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'PSEUDOLIPID COMPLEX MIXTURE AND A SKIN EXTERNAL APPLICATION COMPOSITION CONTAINING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/003519
[patent_app_country] => US
[patent_app_date] => 2008-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3536
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20110118222.pdf
[firstpage_image] =>[orig_patent_app_number] => 13003519
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/003519 | Pseudolipid complex mixture and a skin external application composition containing same | Sep 1, 2008 | Issued |
Array
(
[id] => 5338043
[patent_doc_number] => 20090054507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'CONTROL OF MALIGNANT CELLS BY KINASE INHIBITION'
[patent_app_type] => utility
[patent_app_number] => 12/201693
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 17799
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054507.pdf
[firstpage_image] =>[orig_patent_app_number] => 12201693
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/201693 | CONTROL OF MALIGNANT CELLS BY KINASE INHIBITION | Aug 28, 2008 | Abandoned |
Array
(
[id] => 5453387
[patent_doc_number] => 20090069424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'TGF-alpha expression inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/230137
[patent_app_country] => US
[patent_app_date] => 2008-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4031
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20090069424.pdf
[firstpage_image] =>[orig_patent_app_number] => 12230137
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/230137 | TGF-alpha expression inhibitors | Aug 24, 2008 | Abandoned |